Hydrophobic plant antioxidants. preparation of nanoparticles and their application for prevention of neurodegenerative diseases.review and experimental data

Current Topics in Medicinal Chemistry

Volumn 14, Issue 22, 2014, Pages 2520-2528

  Muronetz, Vladimir ^a   Asryants, Regina ^a   Semenyuk, Pavel ^a   Schmalhausen, Elena ^a   Saso, Luciano ^b  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

2 hydroxypropylbeta cyclodextrin; Glyceraldehyde 3 phosphate dehydrogenase; Hydrophobic plant antioxidants; Oxidative stress

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; 5,7 DIHYDROXY 4 (2 PYRIDYL) COUMARIN; 5,7 DIHYDROXY 6 OCTANOYL 4 PHENYLCOUMARIN; 5,7 DIHYDROXY 8 (3 METHYLBUTANOYL) 6 PRENYL 4 PHENYLCOUMARIN; 5,7 DIHYDROXY 8 OCTANOYL 4 PHENYLCOUMARIN; 5,7 DIHYDROXY 8 PRENYL 6 (2 METHYLBUTANOYL) 4 PHENYLCOUMARIN; 7 HYDROXYPRENYL 4 PHENYLCOUMARIN; 8 HYDROXY 4 PHENYL 2H BENZO(H)CHROMEN 2ONE; AMYLOID BETA PROTEIN; AMYLOID PROTEIN; ANTIOXIDANT; ASCORBIC ACID; CHAPERONE; CHAPERONIN; DEFEROXAMINE; GLYCERALDEHYDE 3 PHOSPHATE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; NANOPARTICLE; PRION PROTEIN; QUERCETIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CHEMICAL MODIFICATION; DEGENERATIVE DISEASE; DISEASE COURSE; DRUG MECHANISM; ENZYME ACTIVITY; GLYCOLYSIS; HUNTINGTON CHOREA; HYDROPHOBICITY; LIGHT SCATTERING; MOLECULAR WEIGHT; NERVE DEGENERATION; NUCLEAR EXPORT SIGNAL; OXIDATION; OXIDATIVE STRESS; PARKINSON DISEASE; PRION DISEASE; PROTEIN AGGREGATION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; CHEMICAL PHENOMENA; CHEMISTRY; DRUG EFFECTS; HUMAN; NEURODEGENERATIVE DISEASES;

ANTIOXIDANTS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; NANOPARTICLES; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS;

EID: 84921852122     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026614666141203124057     Document Type: Article

References (50)

1. Hwang, N.R.; Yim, S.-H.; Kim, Y.M.; Jeong, J.; Song, E.J.; Lee, Y.; Lee, J.H.; Choi, S.; Lee, K.-J. Oxidative Modifications of Glyceraldehyde- 3-Phosphate Dehydrogenase Play a Key Role in Its Multiple Cellular Functions. Biochem. J., 2009, 423, 253-264.
2. Hancock, J.; Desikan, R.; Harrison, J.; Bright, J.; Hooley, R.; Neill, S. Doing the Unexpected: Proteins Involved in Hydrogen Peroxide Perception. J. Exp. Bot., 2006, 57, 1711-1718.
3. Mazzola, J.L.; Sirover, M.A. Reduction of Glyceraldehyde-3- Phosphate Dehydrogenase Activity in Alzheimer's Disease and in Huntington's Disease Fibroblasts. J. Neurochem., 2001, 76, 442- 449.
4. Mazzola, J.L.; Sirover, M.A. Alteration of Intracellular Structure and Function of Glyceraldehyde-3-Phosphate Dehydrogenase: A Common Phenotype of Neurodegenerative Disorders? Neurotoxicology, 2002, 23, 603-609.
5. Shenton, D.; Perrone, G.; Quinn, K.A.; Dawes, I.W.; Grant, C.M. Regulation of Protein S-Thiolation by Glutaredoxin 5 in the Yeast Saccharomyces Cerevisiae. J. Biol. Chem., 2002, 277, 16853- 16859.
6. Allison, W.S.; Connors, M.J. The Activation and Inactivation of the Acyl Phosphatase Activity of Glyceraldehyde-3-Phosphate Dehydrogenase. Arch. Biochem. Biophys., 1970, 136, 383-391.
7. Arutyunov, D.Y.; Muronetz, V.I. The Activation of Glycolysis Performed by the Non-Phosphorylating Glyceraldehyde-3- Phosphate Dehydrogenase in the Model System. Biochem. Biophys. Res. Commun., 2003, 300, 149-154.
8. Danshina, P.V.; Schmalhausen, E.V.; Avetisyan, A.V.; Muronetz, V.I. Mildly Oxidized Glyceraldehyde-3-Phosphate Dehydrogenase as a Possible Regulator of Glycolysis. IUBMB Life, 2001, 51, 309- 314.
9. Dan'shina, P.V.; Schmalhausen, E.V.; Arutiunov, D.Y.; Pleten, A.P.; Muronetz, V.I. Acceleration of Glycolysis in the Presence of the Non-Phosphorylating and the Oxidized Phosphorylating Glyceraldehyde- 3-Phosphate Dehydrogenases. Biochemistry (Mosc). 2003, 68, 593-600.
10. Schmalhausen, E.V.; Muronetz, V.I. An Uncoupling of the Processes of Oxidation and Phosphorylation in Glycolysis. Biosci. Rep., 1997, 17, 521-527.
11. Schmalhausen, E.V.; Nagradova, N.K.; Boschi-Muller, S.; Branlant, G.; Muronetz, V.I. Mildly Oxidized GAPDH: The Coupling of the Dehydrogenase and Acyl Phosphatase Activities. FEBS Lett., 1999, 452, 219-222.
12. Martínez, A.; Portero-Otin, M.; Pamplona, R.; Ferrer, I. Protein Targets of Oxidative Damage in Human Neurodegenerative Diseases with Abnormal Protein Aggregates. Brain Pathol. Zurich Switz., 2010, 20, 281-297.
13. Hoyer, S.; Nitsch, R.; Oesterreich, K. Predominant Abnormality in Cerebral Glucose Utilization in Late-Onset Dementia of the Alzheimer Type: A Cross-Sectional Comparison against Advanced Late-Onset and Incipient Early-Onset Cases. J. Neural Transm. Park. Dis. Dement. Sect., 1991, 3, 1-14.
14. Kim, E.J.; Cho, S.S.; Jeong, Y.; Park, K.C.; Kang, S.J.; Kang, E.; Kim, S.E.; Lee, K.H.; Na, D.L. Glucose Metabolism in Early Onset versus Late Onset Alzheimer's Disease: An SPM Analysis of 120 Patients. Brain J. Neurol., 2005, 128, 1790-1801.
15. Gómez, A.; Ferrer, I. Increased Oxidation of Certain Glycolysis and Energy Metabolism Enzymes in the Frontal Cortex in Lewy Body Diseases. J. Neurosci. Res., 2009, 87, 1002-1013.
16. Yong, S.W.; Yoon, J.K.; An, Y.S.; Lee, P.H. A Comparison of Cerebral Glucose Metabolism in Parkinson's Disease, Parkinson's Disease Dementia and Dementia with Lewy Bodies. Eur. J. Neurol. Off. J. Eur. Fed. Neurol. Soc., 2007, 14, 1357-1362.
17. Benavides, G. A.; Liang, Q.; Dodson, M.; Darley-Usmar, V.; Zhang, J. Inhibition of Autophagy and Glycolysis by Nitric Oxide during Hypoxia-Reoxygenation Impairs Cellular Bioenergetics and Promotes Cell Death in Primary Neurons. Free Radic. Biol. Med., 2013, 65, 1215-1228.
18. Dodson, M.; Liang, Q.; Johnson, M.S.; Redmann, M.; Fineberg, N.; Darley-Usmar, V.M.; Zhang, J. Inhibition of Glycolysis Attenuates 4-Hydroxynonenal-Dependent Autophagy and Exacerbates Apoptosis in Differentiated SH-SY5Y Neuroblastoma Cells. Autophagy, 2013, 9, 1996-2008.
19. Nciri, R.; Desmoulin, F.; Allagui, M. S.; Murat, J.-C.; Feki, A. E.; Vincent, C.; Croute, F. Neuroprotective Effects of Chronic Exposure of SH-SY5Y to Low Lithium Concentration Involve Glycolysis Stimulation, Extracellular Pyruvate Accumulation and Resistance to Oxidative Stress. Int. J. Neuropsychopharmacol. Off. Sci. J. Coll. Int. Neuropsychopharmacol. CINP, 2013, 16, 365-376.
20. Brooks, W.M.; Lynch, P.J.; Ingle, C.C.; Hatton, A.; Emson, P.C.; Faull, R.L.M.; Starkey, M.P. Gene Expression Profiles of Metabolic Enzyme Transcripts in Alzheimer's Disease. Brain Res., 2007, 1127, 127-135.
21. Bigl, M.; Brückner, M.K.; Arendt, T.; Bigl, V.; Eschrich, K. Activities of Key Glycolytic Enzymes in the Brains of Patients with Alzheimer's Disease. J. Neural. Transm. Vienna Aus., 1996, 1999, 106, 499-511.
22. Boyd-Kimball, D.; Sultana, R.; Poon, H.F.; Lynn, B.C.; Casamenti, F.; Pepeu, G.; Klein, J.B.; Butterfield, D.A. Proteomic Identification of Proteins Specifically Oxidized by Intracerebral Injection of Amyloid Beta-Peptide (1-42) into Rat Brain: Implications for Alzheimer's Disease. Neuroscience, 2005, 132, 313-324.
23. Grünblatt, E.; Mandel, S.; Jacob-Hirsch, J.; Zeligson, S.; Amariglo, N.; Rechavi, G.; Li, J.; Ravid, R.; Roggendorf, W.; Riederer, P.; Youdim, M. B.H. Gene Expression Profiling of Parkinsonian Substantia Nigra Pars Compacta; Alterations in Ubiquitin-Proteasome, Heat Shock Protein, Iron and Oxidative Stress Regulated Proteins, Cell Adhesion/cellular Matrix and Vesicle Trafficking Genes. J. Neural. Transm. Vienna Aust., 2004, 111, 1543-1573.
24. Sorolla, M.A.; Rodríguez-Colman, M.J.; Tamarit, J.; Ortega, Z.; Lucas, J.J.; Ferrer, I.; Ros, J.; Cabiscol, E. Protein Oxidation in Huntington Disease Affects Energy Production and Vitamin B6 Metabolism. Free Radic. Biol. Med., 2010, 49, 612-621.
25. Oláh, J.; Klivényi, P.; Gardián, G.; Vécsei, L.; Orosz, F.; Kovacs, G.G.; Westerhoff, H.V.; Ovádi, J. Increased Glucose Metabolism and ATP Level in Brain Tissue of Huntington's Disease Transgenic Mice. FEBS J., 2008, 275, 4740-4755.
26. Shalova, I.N.; Cechalova, K.; Rehakova, Z.; Dimitrova, P.; Ognibene, E.; Caprioli, A.; Schmalhausen, E.V.; Muronetz, V.I.; Saso, L. Decrease of Dehydrogenase Activity of Cerebral Glyceraldehyde- 3-Phosphate Dehydrogenase in Different Animal Models of Alzheimer's Disease. Biochim. Biophys. Acta, 2007, 1770, 826- 832.
27. Zala, D.; Hinckelmann, M.-V.; Yu, H.; Lyra da Cunha, M.M.; Liot, G.; Cordelières, F.P.; Marco, S.; Saudou, F. Vesicular Glycolysis Provides on-Board Energy for Fast Axonal Transport. Cell, 2013, 152, 479-491.
28. Cerella, C.; D'Alessio, M.; Cristofanon, S.; De Nicola, M.; Radogna, F.; Dicato, M.; Diederich, M.; Ghibelli, L. Subapoptogenic Oxidative Stress Strongly Increases the Activity of the Glycolytic Key Enzyme Glyceraldehyde 3-Phosphate Dehydrogenase. Ann. N. Y. Acad. Sci., 2009, 1171, 583-590.
29. Arutyunova, E.I.; Danshina, P.V.; Domnina, L.V.; Pleten, A.P.; Muronetz, V.I. Oxidation of Glyceraldehyde-3-Phosphate Dehydrogenase Enhances Its Binding to Nucleic Acids. Biochem. Biophys. Res. Commun. 2003, 307, 547-552.
30. Arutyunova, E.I.; Domnina, L.V.; Chudinova, A.A.; Makshakova, O.N.; Arutyunov, D.Y.; Muronetz, V.I. Localization of Non-Native D-Glyceraldehyde-3-Phosphate Dehydrogenase in Growing and Apoptotic HeLa Cells. Biochemistry (Mosc). 2013, 78, 91-95.
31. Tatton, W.G.; Chalmers-Redman, R.M.; Elstner, M.; Leesch, W.; Jagodzinski, F.B.; Stupak, D.P.; Sugrue, M.M.; Tatton, N.A. Glyceraldehyde- 3-Phosphate Dehydrogenase in Neurodegeneration and Apoptosis Signaling. J. Neural. Transm. Suppl., 2000, 60, 77-100.
32. Rezaei, H.; Eghiaian, F.; Perez, J.; Doublet, B.; Choiset, Y.; Haertle, T.; Grosclaude, J. Sequential Generation of Two Structurally Distinct Ovine Prion Protein Soluble Oligomers Displaying Different Biochemical Reactivities. J. Mol. Biol., 2005, 347, 665- 679.
33. Kiselev, G.G.; Naletova, I.N.; Sheval, E.V.; Stroylova, Y.Y.; Schmalhausen, E.V.; Haertlé, T.; Muronetz, V.I. Chaperonins Induce an Amyloid-like Transformation of Ovine Prion Protein: The Fundamental Difference in Action between Eukaryotic TRiC and Bacterial GroEL. Biochim. Biophys. Acta - Pro. Proteom., 2011, 1814, 1730-1738.
34. Tatzelt, J.; Zuo, J.; Voellmy, R.; Scott, M.; Hartl, U.; Prusiner, S.B.; Welch, W.J. Scrapie Prions Selectively Modify the Stress Response in Neuroblastoma Cells. Proc. Natl. Acad. Sci. U. S. A, 1995, 92, 2944-2948.
35. DebBurman, S.K.; Raymond, G.J.; Caughey, B.; Lindquist, S. Chaperone-Supervised Conversion of Prion Protein to Its Protease- Resistant Form. Proc. Natl. Acad. Sci. U. S. A, 1997, 94, 13938- 13943.
36. Edenhofer, F.; Rieger, R.; Famulok, M.; Wendler, W.; Weiss, S.; Winnacker, E. L. Prion Protein PrPc Interacts with Molecular Chaperones of the Hsp60 Family. J. Virol., 1996, 70, 4724-4728.
37. Polyakova, O.V.; Roitel, O.; Asryants, R.A.; Poliakov, A.A.; Branlant, G.; Muronetz, V. I. Misfolded Forms of Glyceraldehyde-3- Phosphate Dehydrogenase Interact with GroEL and Inhibit Chaperonin- Assisted Folding of the Wild-Type Enzyme. Pro. Sci. Publ. Pro. Soc., 2005, 14, 921-928.
38. Naletova, I.N.; Muronetz, V.I.; Schmalhausen, E.V. Unfolded, Oxidized, and Thermoinactivated Forms of Glyceraldehyde-3- Phosphate Dehydrogenase Interact with the Chaperonin GroEL in Different Ways. Biochim. Biophys. Acta, 2006, 1764, 831-838.
39. Naletova, I.; Schmalhausen, E.; Kharitonov, A.; Katrukha, A.; Saso, L.; Caprioli, A.; Muronetz, V. Non-Native Glyceraldehyde-3- Phosphate Dehydrogenase Can Be an Intrinsic Component of Amyloid Structures. Biochim. Biophys. Acta, 2008, 1784, 2052-2058.
40. Tamaoka, A.; Endoh, R.; Shoji, S.; Takahashi, H.; Hirokawa, K.; Teplow, D.B.; Selkoe, D.J.; Mori, H. Antibodies to Amyloid Beta Protein (A Beta) Crossreact with Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH). Neurobiol. Aging, 1996, 17, 405-414.
41. Schulze, H.; Schuler, A.; Stüber, D.; Döbeli, H.; Langen, H.; Huber, G. Rat Brain Glyceraldehyde-3-Phosphate Dehydrogenase Interacts with the Recombinant Cytoplasmic Domain of Alzheimer's Beta-Amyloid Precursor Protein. J. Neurochem., 1993, 60, 1915-1922.
42. Chander, H.; Chauhan, A.; Wegiel, J.; Malik, M.; Sheikh, A.; Chauhan, V. Binding of Trypsin to Fibrillar Amyloid Beta-Protein. Brain Res., 2006, 1082, 173-181.
43. Avila, C.L.; Torres-Bugeau, C.M.; Barbosa, L.R.S.; Sales, E.M.; Ouidja, M.O.; Socías, S.B.; Celej, M.S.; Raisman-Vozari, R.; Papy- Garcia, D.; Itri, R.; Chehín, R.N. Structural Characterization of Heparin-Induced Glyceraldehyde-3-Phosphate Dehydrogenase Protofibrils Preventing A-Synuclein Oligomeric Species Toxicity. J. Biol. Chem., 2014, 289, 13838-13850.
44. Schmalhausen, E.V.; Muronetz, V.I. An Uncoupling of the Processes of Oxidation and Phosphorylation in Glycolysis. Biosci. Rep., 1997, 17, 521-527.
45. Schmalhausen, E.V.; Nagradova, N.K.; Boschi-Muller, S.; Branlant, G.; Muronetz, V.I. Mildly Oxidized GAPDH: The Coupling of the Dehydrogenase and Acyl Phosphatase Activities. FEBS Lett., 1999, 452, 219-222.
46. Danshina, P.V.; Schmalhausen, E.V.; Avetisyan, A.V.; Muronetz, V.I. Mildly Oxidized Glyceraldehyde-3-Phosphate Dehydrogenase as a Possible Regulator of Glycolysis. IUBMB Life, 2001, 51, 309- 314.
47. Albina, J.E.; Mastrofrancesco, B.; Reichner, J.S. Acyl Phosphatase Activity of NO-Inhibited Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH): A Potential Mechanism for Uncoupling Glycolysis from ATP Generation in NO-Producing Cells. Biochem. J., 1999, 341 (Pt 1), 5-9.
48. Elkina, Y.L.; Atroshchenko, M.M.; Bragina, E.E.; Muronetz, V.I.; Schmalhausen, E.V. Oxidation of Glyceraldehyde-3-Phosphate Dehydrogenase Decreases Sperm Motility. Biochem. (Mosc). 2011, 76, 268-272.
49. Schmalhausen, E.V.; Pleten', A.P.; Muronetz, V.I. Ascorbate- Induced Oxidation of Glyceraldehyde-3-Phosphate Dehydrogenase. Biochem. Biophys. Res. Commun., 2003, 308, 492-496.
50. Schmalhausen, E.V.; Zhlobek, E.B.; Shalova, I.N.; Firuzi, O.; Saso, L.; Muronetz, V.I. Antioxidant and Prooxidant Effects of Quercetin on Glyceraldehyde-3-Phosphate Dehydrogenase. Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc., 2007, 45, 1988- 1993.